Showing 81–81 of 81 results

Orthopedic Biomaterials, Bone Grafting and Hyaluronic Acid Viscosupplementation Market Report Suite | Asia-Pacific | 2011-2017 | MedSuite

The Asia-Pacific markets include Australia, China, Japan and South Korea. The orthopedic biomaterials market comprises autologous bone grafts, bone graft substitutes (segmented into allografts, demineralized bone matrices and synthetics), hyaluronic acid (HA) viscosupplementation and bone morphogenetic protein (BMP) growth factor therapy. The market is approaching maturity, but is expected to continue to grow as a result of the aging Asia-Pacific population. BMP growth factor therapy was the fastest-growing segment in 2010, increasing almost 7% over the previous year.